Category
Today's News
More News
Weekly Update of Drug News-4/9/2025

Weekly Update of Drug News-4/9/2025

On Aug 21, 2025, Abbvie announced that positive results from study 1 of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of RINVOQ® (Upadacitinib) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline

Weekly Update of Drug News-4/9/2025

On Aug 21, 2025, Abbvie announced that positive results from study 1 of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of RINVOQ® (Upadacitinib) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...